Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Sell
51,434
-21,446
-29% -$6.8M 0.26% 52
2026
Q1
$18.3M Sell
72,880
-10,000
-12% -$2.22M 0.3% 48
2025
Q4
$13.4M Sell
82,880
-71,265
-46% -$12.4M 0.23% 50
2025
Q3
$23.3M Sell
154,145
-195,650
-56% -$26.1M 0.41% 43
2025
Q2
$44.9M Buy
349,795
+35,000
+11% +$3.4M 1% 32
2025
Q1
$22.7M Hold
314,795
0.58% 41
2024
Q4
$35.8M Sell
314,795
-80,108
-20% -$9.51M 0.94% 35
2024
Q3
$39.3M Buy
394,903
+11,718
+3% +$971K 1.07% 37
2024
Q2
$33.2M Buy
383,185
+328,185
+597% +$29.9M 1.12% 39
2024
Q1
$4.49M Buy
+55,000
New +$3.46M 0.16% 52

Other funds holding VRT

W.H. Reaves & Co's VRT Position: Q2 2026 in Review

W.H. Reaves & Co reduced its Vertiv (VRT) stake by 29% in Q2 2026, selling an estimated $6.8M and leaving 51,434 shares worth $17.2M. The position accounts for 0.26% of the portfolio, ranked #52.

W.H. Reaves & Co first reported a position in VRT in Q1 2024 and has held it in 10 quarters since. The position peaked at $44.9M in Q2 2025. 2,049 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • W.H. Reaves & Co held 51,434 shares of Vertiv worth $17.2M as of Q2 2026.
  • W.H. Reaves & Co sold 21,446 Vertiv shares in Q2 2026, an estimated $6.8M.
  • Vertiv made up 0.26% of W.H. Reaves & Co's portfolio in Q2 2026, its #52 holding.
  • W.H. Reaves & Co first reported a position in Vertiv in Q1 2024 and has held it in 10 quarters since.
  • W.H. Reaves & Co's Vertiv position peaked at $44.9M in Q2 2025.
  • 2,049 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on W.H. Reaves & Co's 13F filing for Q2 2026, filed 30 Jul 2026.